Home/Annexon Biosciences/Ted Yednock, PhD
TY

Ted Yednock, PhD

EVP & Chief Innovation Officer

Annexon Biosciences

Roles

EVP & Chief Innovation OfficeratAnnexon Biosciences
EVP & Chief Innovation OfficeratAnnexon

Annexon Biosciences Pipeline

DrugIndicationPhase
ANX005Guillain-Barré Syndrome (GBS)Phase 3
ANX007Geographic Atrophy (GA)Phase 2
ANX009Undisclosed (Blood/Targeted)Phase 1
ANX1502Undisclosed (Oral)Phase 1